COVID19 Pandemic

Los qué todos leen
Author : Dr. Atanas G. Atanasov Is a leading scientist interested
in molecular medicine and digital health, PI of LBIDHPS, Editorin
Chief of CRBIOTECH and Executive Director of INPST. Social media
contacts: Twitter, LinkedIn, Facebook .
holds a MSc degree in Biotechnology, PhD degree in Biochemistry and
Habilitation (Privatdozent (PD) degree) in Pharmaceutical Biology
(issued from the University of Vienna, Austria).
He is currently Principle Investigator of Ludwig Boltzmann Institute for Digital
Health and Patient Safety at Medical University of Vienna (Austria),
Adjunct Professor at IGAB PAS (Poland), Guest-Professor at Bulgarian
Academy of Sciences (Bulgaria), Guest-Lecturer at the University of
Vienna (Austria) and Editor-in-Chief of Current Research in Biotechnology
(Elsevier). Dr Atanasov has published over 200 papers with a focus
on Molecular Medicine, Biotechnology and Natural Products. Moreover,
he is a pioneer in digital science communication approaches (e.g., using
diverse social media networks, including a Twitter channel with over
100,000 followers) and was named #11 in the world on the “Top 25 biotech
influencers to watch on Twitter” and #44 in the world on the “Twitter
top 100 – scientist” rankings by Disruptor Daily and Finster Data, respectively.
Moreover, he is the Founder and Executive
Director of the International Natural Product Sciences Taskforce (INPST),
an open innovation platform bringing together scientists and key opinion
leaders of the natural product scientific research field, as well as members
of multiple scientific excellence centers and pharmaceutical-, biotech-,
healthtech- and natural product-related industries, united with the
aim to promote collaborative natural product-linked research, technology
development, health literacy and biomedical science communication
Los qué Todos Leen 67